You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 216 Tissue nanomechanical signature as a novel, clinically translatable predictor of response to immunotherapy combined with low-dose radiation

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
216 Tissue nanomechanical signature as a novel, clinically translatable predictor of response to immunotherapy combined with low-dose radiation

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023114014
Dec 20236307
Jan 20242402
Feb 20242201
Mar 20245801
Apr 20242002
May 20243200
Jun 20241000
Jul 20241601
Aug 20243402
Sep 20244402
Oct 20243006
Nov 20244405
Dec 2024603
Jan 20253205
Feb 2025203
Mar 2025002
Apr 2025103
May 2025004
Jun 2025004
Total552067